Results 111 to 120 of about 181,126 (162)
Some of the next articles are maybe not open access.
Ipilimumab/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2020openaire +2 more sources
Pathobiology
Introduction: This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC). Methods: A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014.
Ana Blanca +6 more
openaire +3 more sources
Introduction: This study aimed to evaluate the prognostic significance of programmed cell death (PD)-1/PD-ligand 1 (PD-L1), PD-ligand 2 (PD-L2), and fibroblast growth factor receptor 3 (FGFR3) expression in bladder cancer (BC). Methods: A retrospective study was conducted on BC patients who underwent transurethral resection between 2005 and 2014.
Ana Blanca +6 more
openaire +3 more sources
Programmed-cell-death-1-receptor-antagonists /rituximab
Reactions Weekly, 2022openaire +1 more source
Lenvatinib/programmed cell death-1 receptor antagonists
Reactions Weekly, 2022openaire +1 more source
Anti‐program cell death receptor‐1 induced erythema nodosum
Dermatologic Therapy, 2022Caroline Gerhardt +5 more
openaire +2 more sources
Veterinary Immunology and Immunopathology
Immunomodulatory antibody drugs that modulate the function of immune checkpoint molecules, such as programmed death receptor-1 (PD-1) and programmed cell death ligand 1 (PD-L1), have been established as new cancer treatments in human medicine. In recent years, there have also been reports on antibodies that inhibit immune checkpoint molecules in dogs ...
Takuya, Mizuno +3 more
openaire +2 more sources
Immunomodulatory antibody drugs that modulate the function of immune checkpoint molecules, such as programmed death receptor-1 (PD-1) and programmed cell death ligand 1 (PD-L1), have been established as new cancer treatments in human medicine. In recent years, there have also been reports on antibodies that inhibit immune checkpoint molecules in dogs ...
Takuya, Mizuno +3 more
openaire +2 more sources
Catequentinib/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2023openaire +1 more source
Antineoplastics/programmed-cell-death-1-receptor-antagonists
Reactions Weekly, 2023openaire +1 more source